Logo image of XAM.CA

XANADU MINES LTD (XAM.CA) Stock Fundamental Analysis

TSX:XAM - Toronto Stock Exchange - AU000000XAM0 - Common Stock - Currency: CAD

0.075  0 (0%)

Fundamental Rating

3

Taking everything into account, XAM scores 3 out of 10 in our fundamental rating. XAM was compared to 805 industry peers in the Metals & Mining industry. The financial health of XAM is average, but there are quite some concerns on its profitability. XAM shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

XAM had negative earnings in the past year.
In the past year XAM has reported a negative cash flow from operations.
XAM had negative earnings in each of the past 5 years.
In the past 5 years XAM always reported negative operating cash flow.
XAM.CA Yearly Net Income VS EBIT VS OCF VS FCFXAM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

XAM has a Return On Assets of -9.78%. This is in the better half of the industry: XAM outperforms 60.99% of its industry peers.
The Return On Equity of XAM (-9.99%) is better than 64.97% of its industry peers.
Industry RankSector Rank
ROA -9.78%
ROE -9.99%
ROIC N/A
ROA(3y)-10.1%
ROA(5y)-10.6%
ROE(3y)-10.52%
ROE(5y)-11.27%
ROIC(3y)N/A
ROIC(5y)N/A
XAM.CA Yearly ROA, ROE, ROICXAM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5 -10 -15

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for XAM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XAM.CA Yearly Profit, Operating, Gross MarginsXAM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200K -400K -600K -800K

More info and screens

5

2. Health

2.1 Basic Checks

XAM does not have a ROIC to compare to the WACC, probably because it is not profitable.
XAM has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, XAM has more shares outstanding
The debt/assets ratio for XAM is higher compared to a year ago.
XAM.CA Yearly Shares OutstandingXAM.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
XAM.CA Yearly Total Debt VS Total AssetsXAM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 76.15 indicates that XAM is not in any danger for bankruptcy at the moment.
The Altman-Z score of XAM (76.15) is better than 91.68% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that XAM is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.00, XAM perfoms like the industry average, outperforming 54.04% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 76.15
ROIC/WACCN/A
WACC9.9%
XAM.CA Yearly LT Debt VS Equity VS FCFXAM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

XAM has a Current Ratio of 5.02. This indicates that XAM is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 5.02, XAM is doing good in the industry, outperforming 75.28% of the companies in the same industry.
A Quick Ratio of 5.02 indicates that XAM has no problem at all paying its short term obligations.
The Quick ratio of XAM (5.02) is better than 75.78% of its industry peers.
Industry RankSector Rank
Current Ratio 5.02
Quick Ratio 5.02
XAM.CA Yearly Current Assets VS Current LiabilitesXAM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.89% over the past year.
The Revenue has grown by 1255.56% in the past year. This is a very strong growth!
Measured over the past years, XAM shows a very strong growth in Revenue. The Revenue has been growing by 89.44% on average per year.
EPS 1Y (TTM)14.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.06%
Revenue 1Y (TTM)1255.56%
Revenue growth 3Y395.97%
Revenue growth 5Y89.44%
Sales Q2Q%-20300%

3.2 Future

The Earnings Per Share is expected to grow by 63.71% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 371.27% on average over the next years. This is a very strong growth
EPS Next Y15.87%
EPS Next 2YN/A
EPS Next 3Y-26.97%
EPS Next 5Y63.71%
Revenue Next Year-100%
Revenue Next 2YN/A
Revenue Next 3Y-25.99%
Revenue Next 5Y371.27%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XAM.CA Yearly Revenue VS EstimatesXAM.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2028 2029 2030 2031 2032 50M 100M 150M 200M 250M
XAM.CA Yearly EPS VS EstimatesXAM.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2020 2021 2025 2027 2028 2029 2030 0 0.01 -0.01 0.02 0.03 0.04

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Forward Price/Earnings Ratio is negative for XAM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XAM.CA Price Earnings VS Forward Price EarningsXAM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XAM.CA Per share dataXAM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 0.02

4.3 Compensation for Growth

A cheap valuation may be justified as XAM's earnings are expected to decrease with -26.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3Y-26.97%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for XAM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XANADU MINES LTD

TSX:XAM (7/11/2025, 7:00:00 PM)

0.075

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-08 2025-05-08
Earnings (Next)07-29 2025-07-29
Inst Owners8.88%
Inst Owner ChangeN/A
Ins Owners22.87%
Ins Owner ChangeN/A
Market Cap171.84M
Analysts80
Price Target0.15 (100%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-15.01%
PT rev (3m)-15.01%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1564.28
P/FCF N/A
P/OCF N/A
P/B 2.73
P/tB 2.73
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.78%
ROE -9.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-10.1%
ROA(5y)-10.6%
ROE(3y)-10.52%
ROE(5y)-11.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1618.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.02
Quick Ratio 5.02
Altman-Z 76.15
F-Score5
WACC9.9%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)43609.7%
Cap/Sales(5y)329246%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.06%
EPS Next Y15.87%
EPS Next 2YN/A
EPS Next 3Y-26.97%
EPS Next 5Y63.71%
Revenue 1Y (TTM)1255.56%
Revenue growth 3Y395.97%
Revenue growth 5Y89.44%
Sales Q2Q%-20300%
Revenue Next Year-100%
Revenue Next 2YN/A
Revenue Next 3Y-25.99%
Revenue Next 5Y371.27%
EBIT growth 1Y18.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-30.94%
EBIT Next 3Y-0.64%
EBIT Next 5Y102.18%
FCF growth 1Y-35.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.5%
OCF growth 3YN/A
OCF growth 5YN/A